Biotech: Pressemitteilungen - Kategorie - Seite 61

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Five Choate Attorneys Named 2016 Boston "Lawyers of the Year" by Best Lawyers in America

BOSTON, MA: BOSTON, MA -- (Marketwired) -- 09/15/15 -- announced today that five partners at the firm -- , , , , and -- have been named a 2016 Boston "Lawyer of the Year" by ®. This designation is g ...

Flamel Technologies to Present at Ladenburg Thalmann 2015 Healthcare Conference

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/15/15 -- Flamel Technologies (NASDAQ: FLML) today announced that the Company will be presenting at the Ladenburg Thalmann 2015 Healthcare Conference to be held at ...

Boston Therapeutics' BTI-320 in Clinical Trial Significantly Reduces Both Glucose and Fructose Levels in Blood

MANCHESTER, NH: Interim Clinical Results of BTI-320 on Post-Prandial Hyperglycemia in High-Risk Chinese Subjects With Pre-Diabetes ...

Novimmune Sponsors Matthew and Andrew Akin Foundation '700 Miles to Hope' Bicycle Ride

GENEVA, SWITZERLAND: GENEVA, SWITZERLAND -- (Marketwired) -- 09/14/15 -- Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory dise ...

Hemostemix Executes Strategic Alliance with Hemostemix Asia for Expansion of Phase-2 Clinical Trial to Taiwan

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/14/15 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM), a clinical-stage autologous cell-therapy company, announced to ...

M Pharmaceutical's CEO Issues Letter to Shareholders

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/10/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company"), a clinical-stage company developing innovative ...

Theravance Biopharma Presents Positive Clinical Data on Fixed-Dose Combination (FDC) of Axelopran (TD-1211) and Oxycodone at PAINWeek(R) 2015

DUBLIN, IRELAND: FDC Designed to Offer Pain Relief Without Opioid-Induced Constipation (OIC); Study Results Demonstrate Bioequivalence of Oxycodone From FDC Compared to Individual Components With No Significant Impact ...

Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies

LONDON, ONTARIO: UHN (University Health Network) agreement transitions Sernova to an integrated therapeutic cell regenerative medicine Company ...

iBio Fibrosis Therapeutics Program Receives NIH Grant Support

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 09/09/15 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, announced the award of a g ...

Flamel Technologies Announces FDA Acceptance of Third NDA Filing

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/09/15 -- Flamel Technologies (NASDAQ: FLML) today announced that it has received a Prescription Drug User Fee Act (PDUFA) date of April 30, 2016 from the U.S. Food ...

Calyx's Subsidiary Cannigistics Announces Platform Licensing Agreement

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/09/15 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or "the Company") is pleased to announce that its wholly-owned sub ...

Sun BioPharma Adopts OTCPink Symbol SNBP

MINNEAPOLIS, MN: Company's Clinical Development Program Focuses on Novel Approach to Treatment of Pancreatic Cancer ...

BioCentury Co-Founder Steps Down as Editor-in-Chief

REDWOOD CITY, CA: Dr. Karen Bernstein to Focus on Chairman's Role; "Editorial Team in Great Hands" as BioCentury Publishes Industry-Shaping 'Back to School' Essay for 23rd Year ...

MedMira Closes Investment from OnSite Lab

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/08/15 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR) has closed the CAD $5 million equity investment with OnSite Lab Holding AG (OnSite Lab) announced Septem ...

Theravance Biopharma to Present New Data Highlighting in vitro Potency of VIBATIV(R) (telavancin) Against Gram-Positive Bacteria, Including MRSA, at 2015 ICAAC

DUBLIN, IRELAND: Presentations Provide Further Confirmation of in vitro Potency Advantage of VIBATIV Against Isolates From Difficult-to-Treat Infections as Compared to Vancomycin, Daptomycin and Linezolid ...

Atossa Genetics Receives Approval to Begin Clinical Study in Israel

SEATTLE, WA: Study to Evaluate Company's ForeCYTE Breast Aspirator Device Will Submit a Subset of Specimens From Carriers of the BRCA Germline Mutation to Contemporary Molecular Tests in Addition to Cytology; ...

Threshold Pharmaceuticals Appoints Mark Hopkins, J.D., Ph.D., Vice President of Intellectual Property and Assistant General Counsel

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/08/15 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced the appointment of Mark Hopkins, J.D., Ph.D., as Vice President of Intellectual ...


Seite 61 von 255:  « ..  60 61 62  63  64  65  66  67  68  69  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z